Literature DB >> 31773047

Large Malignant Fibrous Histiocytoma Treated with Hypofractionated Proton Beam Therapy and Local Hyperthermia.

Takashi Iizumi1, Shosei Shimizu1, Haruko Numajiri1, Hideyuki Takei1, Noboru Yamada2, Masashi Mizumoto1, Hitoshi Ishikawa1, Toshiyuki Okumura1, Hideyuki Sakurai1.   

Abstract

PURPOSE: Malignant fibrous histiocytoma (MFH) is one of the most common soft tissue sarcomas. The standard treatment is adequate surgical resection; in addition, radiation therapy plays a major role in perioperative treatment in most cases. Herein, we report the case of a patient with a large MFH who was successfully treated with combined proton beam therapy (PBT) and local hyperthermia (LH). CASE
PRESENTATION: A 60-year-old man presented with a 6×4-cm mass on his left thigh. Histopathology and immunohistochemistry indicated MFH, and he refused limb amputation. He received treatment with PBT at a dose at 72 GyE in 18 fractions. To cover the entire large target lesion, we used a patch-field protocol. He also concurrently received 7 courses of LH. The combination therapy achieved long-term local control without severe acute or late toxicity during the 7-year follow-up period.
CONCLUSIONS: This case suggests that the combination of PBT and LH may be an option as a limb-preserving treatment for large inoperable MFH in the extremities. ©Copyright 2019 The Author(s).

Entities:  

Keywords:  hyperthermia; limb preservation; proton therapy; radiation therapy; soft tissue sarcoma

Year:  2019        PMID: 31773047      PMCID: PMC6871629          DOI: 10.14338/IJPT-18-00046.1

Source DB:  PubMed          Journal:  Int J Part Ther        ISSN: 2331-5180


  23 in total

Review 1.  Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas.

Authors:  Thomas F DeLaney; Alexei V Trofimov; Martijn Engelsman; Herman D Suit
Journal:  Cancer Control       Date:  2005 Jan-Feb       Impact factor: 3.302

2.  The heat is (still) on--the past and future of hyperthermic radiation oncology.

Authors:  Jens Overgaard
Journal:  Radiother Oncol       Date:  2013-11       Impact factor: 6.280

3.  Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma.

Authors:  A M Davis; B O'Sullivan; R S Bell; R Turcotte; C N Catton; J S Wunder; P Chabot; A Hammond; V Benk; M Isler; C Freeman; K Goddard; A Bezjak; R A Kandel; A Sadura; A Day; K James; D Tu; J Pater; B Zee
Journal:  J Clin Oncol       Date:  2002-11-15       Impact factor: 44.544

Review 4.  Proton beam therapy in Japan: current and future status.

Authors:  Hideyuki Sakurai; Hitoshi Ishikawa; Toshiyuki Okumura
Journal:  Jpn J Clin Oncol       Date:  2016-08-17       Impact factor: 3.019

5.  Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.

Authors:  J C Yang; A E Chang; A R Baker; W F Sindelar; D N Danforth; S L Topalian; T DeLaney; E Glatstein; S M Steinberg; M J Merino; S A Rosenberg
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

6.  Results of carbon ion radiotherapy for head and neck cancer.

Authors:  Jun-Etsu Mizoe; Azusa Hasegawa; Keiichi Jingu; Ryo Takagi; Hiroki Bessyo; Takamichi Morikawa; Morio Tonoki; Hiroshi Tsuji; Tadashi Kamada; Hirohiko Tsujii; Yoshitaka Okamoto
Journal:  Radiother Oncol       Date:  2012-02-08       Impact factor: 6.280

7.  Carbon ion radiotherapy for localized primary sarcoma of the extremities: results of a phase I/II trial.

Authors:  Shinji Sugahara; Tadashi Kamada; Reiko Imai; Hiroshi Tsuji; Noriaki Kameda; Tohru Okada; Hirohiko Tsujii; Shinichirou Tatezaki
Journal:  Radiother Oncol       Date:  2012-10-12       Impact factor: 6.280

8.  Could hyperthermia with proton therapy mimic carbon ion therapy? Exploring a thermo-radiobiological rationale.

Authors:  Niloy R Datta; Emsad Puric; Ralf Schneider; Damien C Weber; Susanne Rogers; Stephan Bodis
Journal:  Int J Hyperthermia       Date:  2014-10-14       Impact factor: 3.914

9.  From the archives of the AFIP. Musculoskeletal malignant fibrous histiocytoma: radiologic-pathologic correlation.

Authors:  M D Murphey; T M Gross; H G Rosenthal
Journal:  Radiographics       Date:  1994-07       Impact factor: 5.333

10.  Bone fractures following external beam radiotherapy and limb-preservation surgery for lower extremity soft tissue sarcoma: relationship to irradiated bone length, volume, tumor location and dose.

Authors:  Colleen I Dickie; Amy L Parent; Anthony M Griffin; Sharon Fung; Peter W M Chung; Charles N Catton; Peter C Ferguson; Jay S Wunder; Robert S Bell; Michael B Sharpe; Brian O'Sullivan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-11       Impact factor: 7.038

View more
  2 in total

1.  Nomogram for predicting cancer-specific survival in undifferentiated pleomorphic sarcoma: A Surveillance, Epidemiology, and End Results -based study.

Authors:  Fengshuo Xu; Fanfan Zhao; Xiaojie Feng; Chengzhuo Li; Didi Han; Shuai Zheng; Yue Liu; Jun Lyu
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

Review 2.  The Role of Hypofractionation in Proton Therapy.

Authors:  Alexandre Santos; Scott Penfold; Peter Gorayski; Hien Le
Journal:  Cancers (Basel)       Date:  2022-05-02       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.